Matches in Nanopublications for { ?s ?p "[Interleukin-6 (IL-6) can activate downstream signaling pathways in lung cancer cells, such as the STAT3 pathway, and is reported to be produced by tumor cells with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP498651.RAAk9nxs6Rjq-3dwf1YwkD7ZfuZEuMRwkc9IVCDm4ZDV4130_assertion description "[Interleukin-6 (IL-6) can activate downstream signaling pathways in lung cancer cells, such as the STAT3 pathway, and is reported to be produced by tumor cells with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498651.RAAk9nxs6Rjq-3dwf1YwkD7ZfuZEuMRwkc9IVCDm4ZDV4130_provenance.
- NP1191330.RADpXcXFxke1GcSeu9P702SXYVAdVcbstbOcbBMs85fS0130_assertion description "[Interleukin-6 (IL-6) can activate downstream signaling pathways in lung cancer cells, such as the STAT3 pathway, and is reported to be produced by tumor cells with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1191330.RADpXcXFxke1GcSeu9P702SXYVAdVcbstbOcbBMs85fS0130_provenance.
- assertion description "[Interleukin-6 (IL-6) can activate downstream signaling pathways in lung cancer cells, such as the STAT3 pathway, and is reported to be produced by tumor cells with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Interleukin-6 (IL-6) can activate downstream signaling pathways in lung cancer cells, such as the STAT3 pathway, and is reported to be produced by tumor cells with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1191331.RAcgOb5JZrNftK8zU3ikrDDrl7ZLFvA5e5ovL8NxXO6vk130_assertion description "[Interleukin-6 (IL-6) can activate downstream signaling pathways in lung cancer cells, such as the STAT3 pathway, and is reported to be produced by tumor cells with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1191331.RAcgOb5JZrNftK8zU3ikrDDrl7ZLFvA5e5ovL8NxXO6vk130_provenance.
- assertion description "[Interleukin-6 (IL-6) can activate downstream signaling pathways in lung cancer cells, such as the STAT3 pathway, and is reported to be produced by tumor cells with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP499179.RAPP061IKw24lOwzamdnsqJes17yg1jUhoW_HPZ1BQWZ8130_assertion description "[Interleukin-6 (IL-6) can activate downstream signaling pathways in lung cancer cells, such as the STAT3 pathway, and is reported to be produced by tumor cells with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499179.RAPP061IKw24lOwzamdnsqJes17yg1jUhoW_HPZ1BQWZ8130_provenance.